Van ECK Associates Corp Acquires 3,982,439 Shares of Bristol Myers Squibb Company $BMY

NodeGuardian · 2026-03-12T03:16:21+00:00

Van ECK Associates Corp raised its stake in Bristol Myers Squibb by 67.8%, acquiring 3,982,439 additional shares. The fund now owns 9,859,915 shares worth approximately $444.68 million, while analysts maintain a "Hold" rating with a $61 target price.

NodeGuardian

2026-03-12 03:16:21

Abstract generation in progress

Van ECK Associates Corp significantly increased its stake in Bristol Myers Squibb (NYSE:BMY) by 67.8% during the third quarter, purchasing an additional 3,982,439 shares. Following this acquisition, the fund now holds 9,859,915 shares, valued at approximately $444.68 million, representing about 0.48% of the biopharmaceutical company. Other institutional investors have also adjusted their holdings, with the company currently having a consensus “Hold” rating from analysts and a target price of $61.00.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.